| Icotinib studied in …STUDIED_INderived66 of 66show fewer |
|---|
| → studied in | NCT07806604recruiting Real World Study of Icotinib in Adjuvant Post Surgical Treatment for Stage IA2 High Risk to IB EGFR Mutant Non Small Cell Lung Cancer · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05263947Phase 2 · completed Bevacizumab Combined With Double Doses of Icotinib in Advanced NSCLC Patients With EGFR L858R Mutation · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04206072Phase 2/Phase 3 · completed D-0316 Versus Icotinib in Patients With Locally Advanced or Metastatic EGFR Sensitising Mutation Positive NSCLC · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06955325Phase 3 · not yet recruiting Umbrella Trial of Adjuvant Therapy in Completely Resected High-risk Stage IA-IB NSCLC: Focus on Driver Mutations · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02264210Phase 2 · completed Icotinib for Completed Resected IB NSCLC With EGFR Mutation · 66 trials list this drug (5 active) | — | — | Lung Neoplasm,Lung Large Cell Carcinoma,Lung Non-Small Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05007938Phase 2 · unknown Befotertinib and Icotinib in Treatment-naive Patients With Advanced EGFR-Mutant Lung Cancer · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06517953Phase 2 · recruiting Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations · 66 trials list this drug (5 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01973725Phase 2 · completed Study of Icotinib Hydrochloride in Treating Patients With Recurrent or Metastatic Esophageal Cancer After Failure of Conventional Chemotherapy · 66 trials list this drug (5 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05514314Phase 2 · unknown A Multicenter Prospective Study to Assess the Effects of Adjuvant Icotinib in EGFRm Stage I NSCLC With High-risk of Disease Recurrence After Complete Resection · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02044328Phase 2 · completed Icotinib as an Adjuvant Therapy for Patients With Stage IIA-IIIA Adenocarcinoma With EGFR Mutation · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05132985Phase 2 · not yet recruiting Neoadjuvant Icotinib With Chemotherapy for Epidermal Growth Factor Receptor(EGFR)-Mutated Resectable Lung Adenocarcinoma · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05104788Phase 2 · recruiting A Study of Icotinib With Chemotherapy as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02934256Phase 2 · completed Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors · 66 trials list this drug (5 active) | — | — | Vestibular Schwannoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02448797Phase 3 · unknown Icotinib as Adjuvant Therapy Compared With Standard Chemotherapy in Stage II-IIIA NSCLC With EGFR-mutation · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04797806Phase 3 · unknown Study of Anlotinib Combined With Icotinib as the First-line Treatment in Patients With EGFR Concomitant Mutation NSCLC · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02362230Phase 2 · terminated Evaluation of Icotinib in Metastatic Triple-negative Breast Cancer After Second-line Therapy · 66 trials list this drug (5 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04575415unknown Bevacizumab Plus EGFR-TKIs in Chinese Patients With EGFR-mutant NSCLC: a Real-world Study · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02737774Phase 2 · unknown Alternating Icotinib and Chemotherapy for Advanced Non-small Cell Lung Cancer With EGFR Mutation · 66 trials list this drug (5 active) | — | — | Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02744664Phase 4 · completed Cryotherapy Combine Icotinib for Advanced NSCLC Treatment · 66 trials list this drug (5 active) | — | — | Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04058704Phase 3 · unknown A Study to Determine the Efficiency For Brain Metastasis NSCLC Patients Treated With Icotinib Alone or Combined With Radiation Therapy · 66 trials list this drug (5 active) | — | — | Brain Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01855854Phase 2 · completed Second-line Treatment With Icotinib in Esophageal Carcinoma Patients With EGFR Overexpression (IHC 3+) or Positive FISH · 66 trials list this drug (5 active) | — | — | Esophageal Carcinoma,Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03992885Phase 3 · unknown Clinical Study of Combination Therapy With Ectiecinib, Pemetrexed and Platinum in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer With EGFR Mutations. · 66 trials list this drug (5 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03983811NA · unknown Adjuvant Chemotherapy With or Without Intercalated Icotinib · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02889692Phase 3 · completed Clinical Study of Chinese Medicine Plus Targeted Therapy Maintenance in Advanced Pulmonary Adenocarcinoma · 66 trials list this drug (5 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02726568Phase 2 · unknown High Dose Icotinib With Sequential SRS For NSCLC Patients Harboring EGFR Mutation With Brain Metastases · 66 trials list this drug (5 active) | — | — | Brain Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03766490NA · unknown Anlotinib Hydrochloride Combined With EGFR TKIs in Advanced Non-small Cell Lung Cancer · 66 trials list this drug (5 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03754530Phase 2 · unknown Icotinib Combined With Radiation Therapy For NSCLC Patients With Brain Metastases and EGFR Mutation · 66 trials list this drug (5 active) | — | — | Brain Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03749213Phase 2 · unknown Icotinib as Neoadjuvant Therapy in EGFR-mutant Stage ⅢA-N2 Non-small Cell Lung Cancer · 66 trials list this drug (5 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03349203Phase 2 · unknown Icotinib as Neoadjuvant and Adjuvant Therapy in EGFR-mutant Stage IIIB or Oligometastasis Non-small Cell Lung Cancer · 66 trials list this drug (5 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03396185Phase 2 · unknown Icotinib as Consolidation Therapy After Chemoradiotherapy in EGFR-Mutant Stage IIIA-IIIB Non-small Cell Lung Cancer · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02125240Phase 3 · unknown Icotinib Versus Placebo as Adjuvant Therapy in EGFR-mutant Lung Adenocarcinoma · 66 trials list this drug (5 active) | — | — | Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03151161Phase 2 · unknown Intermittent and Maintenance of Icotinib in Combination With Pemetrexed/Carboplatin Compared With Icotinib Single Drug in Ⅲb/IV Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation · 66 trials list this drug (5 active) | — | — | Lung Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01534585Phase 1/Phase 2 · completed Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma · 66 trials list this drug (5 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03346811Phase 2 · unknown Efficiency of Icotinib in Plasma ctDNA EGFR Mutation-positive Patients Diagnosed With Lung Cancer · 66 trials list this drug (5 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02404675Phase 4 · unknown High Dose Icotinib in Advanced Non-small Cell Lung Cancer With EGFR 21 Exon Mutation · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03153358Phase 2 · unknown Icotinib Combined With SBRT for Patients With Metastatic Non-squamous NSCLC With EGFR Mutation · 66 trials list this drug (5 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01963195Phase 2 · unknown Evaluation of the High Dose of Icotinib in Advanced Lung Cancer Patients After Failure of Target Therapy · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01724801Phase 3 · completed Icotinib or Whole Brain Irradiation in EGFR-mutant Lung Cancer · 66 trials list this drug (5 active) | — | — | Brain Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02960607Phase 2 · unknown High-dose Icotinib Treatment Beyond Progression in EGFR Mutant NSCLC · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02961270Phase 2 · unknown Icotinib in Non-small Cell Lung Cancer Patients With Uncommon EGFR Mutation · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02883543Phase 3 · unknown First-line Icotinib With Concurrent Radiotherapy for NSCLC With EGFR Mutation · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02820116Phase 2 · unknown The Role of Icotinib in the Perioperative Treatment of IIIA - IIIB NSCLC Patients With EGFR Mutation · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02031601Phase 4 · unknown Intercalated Combination of Chemotherapy and Tyrosine Kinase Inhibitors as First-line Treatment for Patients With Non-Small-Cell Lung Cancer · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02375581Phase 2 · unknown Phase II Study of Icotinib With Concurrent Radiotherapy in Elderly Patients With Esophageal Cancer · 66 trials list this drug (5 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01646450Phase 4 · unknown First-line Treatment With Icotinib in Elder NSCLC EGFR Mutated Patients · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01843647Phase 2 · unknown Neoadjuvant Therapy of Icotinib in Epidermal Growth Factor Receptor Mutated NSCLC Patients · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02024633Phase 1 · unknown Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer · 66 trials list this drug (5 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02062515Phase 2 · unknown Icotinib in Advanced Non-small Cell Lung Cancer (NSCLC) With Hepatic Insufficiency · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02486354Phase 3 · completed Icotinib in Advanced Metastatic Patients With NSCLC Previously Treated With Chemotherapy · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01720901Phase 4 · suspended Increased Dose of Icotinib in Advanced None Small Cell Lung Cancer Patients After Routine Gefitinib Therapy · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02278458Phase 1 · unknown Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer · 66 trials list this drug (5 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02430974Phase 2 · unknown Chemotherapy of NSCLC With or Without Icotinib · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02103257Phase 4 · unknown Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma · 66 trials list this drug (5 active) | — | — | Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02407366Phase 2 · unknown Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung Cancer · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02066870Phase 1 · unknown Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKI · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02009605Phase 2 · unknown Icotinib in Previously Treated Non/Light-smoking Patients With Advanced Squamous Cell Lung Cancer · 66 trials list this drug (5 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02328261Phase 2 · unknown A Phase II Study of Icotinib in Treating Patients With Advanced Nasopharyngeal Carcinoma · 66 trials list this drug (5 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02033148Phase 1 · withdrawn Icotinib Hydrochloride in Treating Patients With Advanced Cancers · 66 trials list this drug (5 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02283424Phase 4 · unknown Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With EGFR Gene Mutation · 66 trials list this drug (5 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02272127Phase 2 · unknown Study of Chemotherapy Plus Icotinib to Treat EGFR Mutation-positive Non-small-cell Lung Cancer · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02191059Phase 2 · unknown Phase II Clinical Study of Intermittent High Dose of Icotinib in Combination With Docetaxel to Treat Lung Cancer · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01514877Phase 2 · completed Icotinib Combined With Whole Brain Radiotherapy in Treating Multiple Brain Metastases From Non-Small Cell Lung Cancer · 66 trials list this drug (5 active) | — | — | Malignant Neoplasm,Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01465243Phase 4 · completed Dose Escalation Of Icotinib In Previously Treated Patients With Routine Dose · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01516983Phase 1/Phase 2 · completed Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation · 66 trials list this drug (5 active) | — | — | Brain Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01040780Phase 3 · completed Safety and Efficacy Study of Icotinb in Non-small Cell Lung Cancer (NSCLC) Patients · 66 trials list this drug (5 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01688713Phase 2 · unknown Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung Cancer · 66 trials list this drug (5 active) | — | — | Brain Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |